vs
Adaptive Biotechnologies Corp（ADPT）与RCI HOSPITALITY HOLDINGS, INC.（RICK）财务数据对比。点击上方公司名可切换其他公司
Adaptive Biotechnologies Corp的季度营收约是RCI HOSPITALITY HOLDINGS, INC.的1.0倍（$71.7M vs $70.9M），RCI HOSPITALITY HOLDINGS, INC.净利率更高（-7.8% vs -18.9%，领先11.2%），Adaptive Biotechnologies Corp同比增速更快（51.0% vs -3.1%），RCI HOSPITALITY HOLDINGS, INC.自由现金流更多（$11.5M vs $1.4M），过去两年Adaptive Biotechnologies Corp的营收复合增速更高（30.8% vs -2.0%）
ExpreS2ion Biotechnologies是一家丹麦生物技术企业，总部位于丹麦霍尔斯霍姆，专注于新型疫苗和免疫疗法产品的研发，在纳斯达克第一北增长市场瑞典板块挂牌上市。
RCI Hospitality控股通过子公司经营脱衣舞俱乐部、夜总会、运动酒吧与餐厅，同时还运营一家为成人俱乐部行业提供服务的传媒会展企业。公司于1995年完成首次公开募股上市，目前在纳斯达克全球市场挂牌交易。
ADPT vs RICK — 直观对比
营收规模更大
ADPT
是对方的1.0倍
$70.9M
营收增速更快
ADPT
高出54.2%
-3.1%
净利率更高
RICK
高出11.2%
-18.9%
自由现金流更多
RICK
多$10.1M
$1.4M
两年增速更快
ADPT
近两年复合增速
-2.0%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $71.7M | $70.9M |
| 净利润 | $-13.6M | $-5.5M |
| 毛利率 | 74.6% | — |
| 营业利润率 | -17.8% | -0.7% |
| 净利率 | -18.9% | -7.8% |
| 营收同比 | 51.0% | -3.1% |
| 净利润同比 | 59.7% | -2354.9% |
| 每股收益（稀释后） | $-0.08 | $-0.60 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ADPTRICK
| Q4 25 | $71.7M | — | ||
| Q3 25 | $94.0M | $70.9M | ||
| Q2 25 | $58.9M | $71.1M | ||
| Q1 25 | $52.4M | $65.9M | ||
| Q4 24 | $47.5M | $71.5M | ||
| Q3 24 | $46.4M | $73.2M | ||
| Q2 24 | $43.2M | $76.2M | ||
| Q1 24 | $41.9M | $72.3M |
净利润ADPTRICK
| Q4 25 | $-13.6M | — | ||
| Q3 25 | $9.5M | $-5.5M | ||
| Q2 25 | $-25.6M | $4.1M | ||
| Q1 25 | $-29.9M | $3.2M | ||
| Q4 24 | $-33.7M | $9.0M | ||
| Q3 24 | $-32.1M | $244.0K | ||
| Q2 24 | $-46.2M | $-5.2M | ||
| Q1 24 | $-47.5M | $774.0K |
毛利率ADPTRICK
| Q4 25 | 74.6% | — | ||
| Q3 25 | 80.7% | — | ||
| Q2 25 | 69.4% | — | ||
| Q1 25 | 67.6% | — | ||
| Q4 24 | 62.0% | — | ||
| Q3 24 | 64.1% | — | ||
| Q2 24 | 55.3% | — | ||
| Q1 24 | 56.9% | — |
营业利润率ADPTRICK
| Q4 25 | -17.8% | — | ||
| Q3 25 | 10.9% | -0.7% | ||
| Q2 25 | -42.5% | 12.2% | ||
| Q1 25 | -56.4% | 12.4% | ||
| Q4 24 | -71.3% | 19.5% | ||
| Q3 24 | -70.3% | 4.8% | ||
| Q2 24 | -109.6% | -3.3% | ||
| Q1 24 | -116.5% | 6.4% |
净利率ADPTRICK
| Q4 25 | -18.9% | — | ||
| Q3 25 | 10.2% | -7.8% | ||
| Q2 25 | -43.5% | 5.7% | ||
| Q1 25 | -56.9% | 4.9% | ||
| Q4 24 | -71.0% | 12.6% | ||
| Q3 24 | -69.1% | 0.3% | ||
| Q2 24 | -107.0% | -6.9% | ||
| Q1 24 | -113.5% | 1.1% |
每股收益（稀释后）ADPTRICK
| Q4 25 | $-0.08 | — | ||
| Q3 25 | $0.06 | $-0.60 | ||
| Q2 25 | $-0.17 | $0.46 | ||
| Q1 25 | $-0.20 | $0.36 | ||
| Q4 24 | $-0.22 | $1.01 | ||
| Q3 24 | $-0.22 | $0.04 | ||
| Q2 24 | $-0.31 | $-0.56 | ||
| Q1 24 | $-0.33 | $0.08 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $70.5M | $33.7M |
| 总债务越低越好 | — | $238.2M |
| 股东权益账面价值 | $218.8M | $261.1M |
| 总资产 | $512.7M | $596.9M |
| 负债/权益比越低杠杆越低 | — | 0.91× |
8季度趋势，按日历期对齐
现金及短期投资ADPTRICK
| Q4 25 | $70.5M | — | ||
| Q3 25 | $55.0M | $33.7M | ||
| Q2 25 | $43.2M | $29.3M | ||
| Q1 25 | $50.6M | $32.7M | ||
| Q4 24 | $47.9M | $34.7M | ||
| Q3 24 | $38.1M | $32.4M | ||
| Q2 24 | $59.8M | $34.9M | ||
| Q1 24 | $71.2M | $20.0M |
总债务ADPTRICK
| Q4 25 | — | — | ||
| Q3 25 | — | $238.2M | ||
| Q2 25 | — | $243.8M | ||
| Q1 25 | — | $244.1M | ||
| Q4 24 | — | — | ||
| Q3 24 | — | $241.1M | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
股东权益ADPTRICK
| Q4 25 | $218.8M | — | ||
| Q3 25 | $204.4M | $261.1M | ||
| Q2 25 | $179.7M | $269.5M | ||
| Q1 25 | $190.4M | $268.8M | ||
| Q4 24 | $202.7M | $269.0M | ||
| Q3 24 | $223.8M | $263.4M | ||
| Q2 24 | $241.6M | $271.2M | ||
| Q1 24 | $274.9M | $285.8M |
总资产ADPTRICK
| Q4 25 | $512.7M | — | ||
| Q3 25 | $490.6M | $596.9M | ||
| Q2 25 | $496.6M | $597.4M | ||
| Q1 25 | $510.9M | $589.8M | ||
| Q4 24 | $539.4M | $586.2M | ||
| Q3 24 | $558.5M | $584.4M | ||
| Q2 24 | $584.9M | $601.0M | ||
| Q1 24 | $620.3M | $609.9M |
负债/权益比ADPTRICK
| Q4 25 | — | — | ||
| Q3 25 | — | 0.91× | ||
| Q2 25 | — | 0.90× | ||
| Q1 25 | — | 0.91× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 0.92× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $2.1M | $13.7M |
| 自由现金流经营现金流 - 资本支出 | $1.4M | $11.5M |
| 自由现金流率自由现金流/营收 | 2.0% | 16.2% |
| 资本支出强度资本支出/营收 | 0.9% | 3.2% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $-48.9M | $34.9M |
8季度趋势，按日历期对齐
经营现金流ADPTRICK
| Q4 25 | $2.1M | — | ||
| Q3 25 | $-7.1M | $13.7M | ||
| Q2 25 | $-12.4M | $13.8M | ||
| Q1 25 | $-28.5M | $8.5M | ||
| Q4 24 | $-12.5M | $13.3M | ||
| Q3 24 | $-27.1M | $15.7M | ||
| Q2 24 | $-17.3M | $15.8M | ||
| Q1 24 | $-38.4M | $10.8M |
自由现金流ADPTRICK
| Q4 25 | $1.4M | — | ||
| Q3 25 | $-7.5M | $11.5M | ||
| Q2 25 | $-13.1M | $10.1M | ||
| Q1 25 | $-29.7M | $5.7M | ||
| Q4 24 | $-12.6M | $7.6M | ||
| Q3 24 | $-27.4M | $10.3M | ||
| Q2 24 | $-19.0M | $9.3M | ||
| Q1 24 | $-39.9M | $3.2M |
自由现金流率ADPTRICK
| Q4 25 | 2.0% | — | ||
| Q3 25 | -8.0% | 16.2% | ||
| Q2 25 | -22.2% | 14.2% | ||
| Q1 25 | -56.7% | 8.6% | ||
| Q4 24 | -26.5% | 10.6% | ||
| Q3 24 | -59.0% | 14.0% | ||
| Q2 24 | -44.1% | 12.3% | ||
| Q1 24 | -95.2% | 4.4% |
资本支出强度ADPTRICK
| Q4 25 | 0.9% | — | ||
| Q3 25 | 0.4% | 3.2% | ||
| Q2 25 | 1.1% | 5.2% | ||
| Q1 25 | 2.4% | 4.3% | ||
| Q4 24 | 0.2% | 8.0% | ||
| Q3 24 | 0.7% | 7.3% | ||
| Q2 24 | 4.0% | 8.4% | ||
| Q1 24 | 3.6% | 10.6% |
现金转化率ADPTRICK
| Q4 25 | — | — | ||
| Q3 25 | -0.75× | — | ||
| Q2 25 | — | 3.40× | ||
| Q1 25 | — | 2.65× | ||
| Q4 24 | — | 1.48× | ||
| Q3 24 | — | 64.14× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | 14.00× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ADPT
| Mrd Business Segment | $61.9M | 86% |
| Immune Medicine Business | $9.8M | 14% |
| Immune Medicine Service Revenue | $100.0K | 0% |
RICK
| Transferred At Point In Time | $60.8M | 86% |
| Food And Merchandise | $10.4M | 15% |
